ncRNA name
hsa_circ_0001821
Specific or universal ncRNAs
Universal ncRNAs
Class
Circular RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
miRNA-124-3p/ZEB1
Cancer name
Gastric Cancer
Cancer site
Stomach
Treatment type
Chemotherapy
Drug
Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Down
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Circ-PVT1 facilitated PTX resistance by up-regulating ZEB1 mediated via miR-124-3p, suggesting an underlying therapeutic strategy for GC.
Tissue resource
paclitaxel-resistant gastric cancer tissues and adjacent paclitaxel-sensitive gastric cancer tissues
normal human gastric epithelial cell lines GES-1
human gastric cancer tumor cell lines MKN-45
human gastric cancer tumor cell lines HGC-27
human gastric cancer tumor cell lines MGC-803
human gastric cancer tumor cell lines AGS
Experiment
RT-PCR,Western blot
Institute
the Yantaishan Hospital
Innovation Biotechnology Co., Ltd
Otwo Biotech Co., Ltd
Otwo Biotech Co., Ltd
Otwo Biotech Co., Ltd
Otwo Biotech Co., Ltd
Country
China
Continent
Asia